RMR Laboratories
Early Stage
Injection-like delivery of cannabis through your skin with a cream
Overview
Raised: $809,007
Rolling Commitments ($USD)
Status
Funded
Reporting Date
12/31/2017
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$14,982
# of Investors
894
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Alcohol, Tobacco, & Recreational Drugs
Tech Sector
Location
Marina Del Rey, California
Have you ever been intrigued about medicinal cannabis, but wary about trying it since you didn’t want to smoke or eat it? Well, what if there was a new way - a better way?
With RMR Laboratories, there is! RMR Laboratories has created a topical cannabis cream that provides injection-like speed and efficacy. Their game-changing product creates an intercellular pathway directly through the skin, and it delivers the active ingredients in a non-toxic, non-traumatic way. These topicals directly and locally address the source of muscle or joint inflammation, and the product uses CBD, which is non-psychoactive. Plus, testimony after testimony shows that RMR’s cream works where nothing else did. In trials, 90% of users felt pain relief within 10 minutes -- and some had their pain disappear completely.
That success has led RMR to secure an exclusive deal with the largest and most profitable company in cannabis, Advanced Nutrients, Inc., as their production and distribution partner. Pre-orders from RMR’s first three markets in Colorado, Oregon, and California have earned $2.2 million in revenue for the first half of 2018. Then, when you consider that RMR has 40 U.S. and worldwide patents pending, and their team has over 60 years experience in healthcare and life sciences and 20 years in cannabis, you see why RMR is poised to be the leader in this industry.
After all, cannabis products are now legal medically in 29 states, and more than 60% of the population believes they should be legal everywhere. The cannabis industry is being driven by the health and wellness sector, which will be worth $25 billion by 2022. RMR can help the 110 million people in the U.S. who suffer from chronic pain, along with another 272 million who suffer from migraines, insomnia, anxiety, arthritis, or depression. And they plan to expand globally.
RMR’s cream is a chance for people to be the best versions of themselves, free from pain and the negative effects of painkillers. RMR is steering the healing properties of cannabis to where it’s needed, and they are truly changing the game.
“Who Should Be Interested in this Offer:”
Do you have a painful injury or chronic pain? Do you believe in the medicinal properties of cannabis, and want it to be available to more people? If yes to either (or both!), then RMR Laboratories is worth your time and attention. Their topical cream technology provides pain relief in non-toxic, non-psychoactive ways. Plus, they’re choosing crowdsource investing over angels and VCs because they want the grassroots champions of the legalizing cannabis movement to be the ones investing in - and benefiting from - their technology. Investing in them means investing in pain relief and a people’s movement….all while earning a little profit, too.
With RMR Laboratories, there is! RMR Laboratories has created a topical cannabis cream that provides injection-like speed and efficacy. Their game-changing product creates an intercellular pathway directly through the skin, and it delivers the active ingredients in a non-toxic, non-traumatic way. These topicals directly and locally address the source of muscle or joint inflammation, and the product uses CBD, which is non-psychoactive. Plus, testimony after testimony shows that RMR’s cream works where nothing else did. In trials, 90% of users felt pain relief within 10 minutes -- and some had their pain disappear completely.
That success has led RMR to secure an exclusive deal with the largest and most profitable company in cannabis, Advanced Nutrients, Inc., as their production and distribution partner. Pre-orders from RMR’s first three markets in Colorado, Oregon, and California have earned $2.2 million in revenue for the first half of 2018. Then, when you consider that RMR has 40 U.S. and worldwide patents pending, and their team has over 60 years experience in healthcare and life sciences and 20 years in cannabis, you see why RMR is poised to be the leader in this industry.
After all, cannabis products are now legal medically in 29 states, and more than 60% of the population believes they should be legal everywhere. The cannabis industry is being driven by the health and wellness sector, which will be worth $25 billion by 2022. RMR can help the 110 million people in the U.S. who suffer from chronic pain, along with another 272 million who suffer from migraines, insomnia, anxiety, arthritis, or depression. And they plan to expand globally.
RMR’s cream is a chance for people to be the best versions of themselves, free from pain and the negative effects of painkillers. RMR is steering the healing properties of cannabis to where it’s needed, and they are truly changing the game.
“Who Should Be Interested in this Offer:”
Do you have a painful injury or chronic pain? Do you believe in the medicinal properties of cannabis, and want it to be available to more people? If yes to either (or both!), then RMR Laboratories is worth your time and attention. Their topical cream technology provides pain relief in non-toxic, non-psychoactive ways. Plus, they’re choosing crowdsource investing over angels and VCs because they want the grassroots champions of the legalizing cannabis movement to be the ones investing in - and benefiting from - their technology. Investing in them means investing in pain relief and a people’s movement….all while earning a little profit, too.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.